Home
Top Videos
Top Searches
Moods
Autumn
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
German Hip-Hop
German Pop
Hip-Hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Schlager
Soundtracks and musicals
Scanned by
Norton
™
Safe Web
ACW updated Depression Trial Results and implications
56:59
|
Download Here
You Might Also Like:
XanaCIDD Topline Results Webinar Recording
57:18
|
Dr. Steve Gourlay, MD & CEO of Actinogen (ASX:ACW), at the PSR Life Science Conference 2024
20:17
|
Wrap up - Australian Dementia Research Forum 2024 from Dr Jack Taylor
1:10
|
ACW updated Depression Trial Results and implications
57:00
|
Actinogen Medical (ASX:ACW): Interview with CEO Dr Steve Gourlay
19:35
|
Actinogen Medical – executive interview
14:46
|
Actinogen Clinical Trials Science Forum 2024 – Pipeline in a Pill
1:02:12
|
ACW $11. 1m Capital Raising
28:04
|
ASX Small and Mid-Cap Conference March 2024 | Actinogen Medical Ltd (ASX:ACW)
20:24
|
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
14:12
|
ACW Australian Dementia Research Forum poster presentation
3:30
|
Actinogen Medical: Developing Xanamem as a promising new therapy for Alzheimer’s disease
3:52
|
Actinogen Medical: Focussed on the treatment of Alzheimer’s disease
6:00
|
Actinogen Medical: XanADu, Xanamem & Cortisol: Oct 2018 Barcelona
5:28
|
Actinogen Medical Xanamem drug for Alzheimer's dementia
4:53
|
Actinogen Medical: Taking a new approach to the treatment of Alzheimer’s disease
2:28
|
Meet the CEO & Chairman of Actinogen Medical
39:41
|
Actinogen Medical with Proactive at ASX Small and Mid Cap Conference
4:57
|
Understanding Alzheimer's Symposium by Actinogen Medical
1:17:22
|
Actinogen Medical: 2022 Annual General Meeting
54:10
|
About
FAQ
Privacy
Terms
Contact
© 2024 Tubidy
